vs
礼来（RNA）与Spire Global, Inc.（SPIR）财务数据对比。点击上方公司名可切换其他公司
Spire Global, Inc.的季度营收约是礼来的1.3倍（$15.8M vs $12.5M），Spire Global, Inc.净利率更高（-176.6% vs -1398.3%，领先1221.7%），礼来同比增速更快（434.0% vs -26.9%），Spire Global, Inc.自由现金流更多（$-16.2M vs $-156.9M），过去两年礼来的营收复合增速更高（138.5% vs -32.6%）
礼来是总部位于美国印第安纳州印第安纳波利斯的跨国制药企业，在18个国家设有办事处，产品销往全球约125个国家。公司由美国内战时期联邦军退伍军人、药剂师伊莱·礼来于1876年创立，品牌名即取自创始人姓名。
Spire Global, Inc.是一家天基云数据与分析服务企业，核心业务依托由大量纳米卫星组成的卫星星座，提供覆盖全球的多领域数据集追踪服务，具体包含船舶航运追踪、航空航行监控以及气象模式观测等相关业务，服务覆盖全球范围。
RNA vs SPIR — 直观对比
营收规模更大
SPIR
是对方的1.3倍
$12.5M
营收增速更快
RNA
高出461.0%
-26.9%
净利率更高
SPIR
高出1221.7%
-1398.3%
自由现金流更多
SPIR
多$140.7M
$-156.9M
两年增速更快
RNA
近两年复合增速
-32.6%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $12.5M | $15.8M |
| 净利润 | $-174.4M | $-28.0M |
| 毛利率 | — | 40.2% |
| 营业利润率 | -1513.5% | -164.1% |
| 净利率 | -1398.3% | -176.6% |
| 营收同比 | 434.0% | -26.9% |
| 净利润同比 | -117.0% | 42.7% |
| 每股收益（稀释后） | $-1.27 | $-0.85 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RNASPIR
| Q4 25 | — | $15.8M | ||
| Q3 25 | $12.5M | $12.7M | ||
| Q2 25 | $3.8M | $19.2M | ||
| Q1 25 | $1.6M | $23.9M | ||
| Q4 24 | $3.0M | $21.7M | ||
| Q3 24 | $2.3M | $28.6M | ||
| Q2 24 | $2.0M | $25.4M | ||
| Q1 24 | $3.5M | $34.8M |
净利润RNASPIR
| Q4 25 | — | $-28.0M | ||
| Q3 25 | $-174.4M | $-19.7M | ||
| Q2 25 | $-157.3M | $119.6M | ||
| Q1 25 | $-115.8M | $-20.7M | ||
| Q4 24 | $-102.3M | $-48.8M | ||
| Q3 24 | $-80.4M | $-12.5M | ||
| Q2 24 | $-70.8M | $-16.6M | ||
| Q1 24 | $-68.9M | $-25.5M |
毛利率RNASPIR
| Q4 25 | — | 40.2% | ||
| Q3 25 | — | 36.6% | ||
| Q2 25 | — | 48.9% | ||
| Q1 25 | — | 36.8% | ||
| Q4 24 | — | 32.4% | ||
| Q3 24 | — | 44.5% | ||
| Q2 24 | — | 43.0% | ||
| Q1 24 | — | 26.5% |
营业利润率RNASPIR
| Q4 25 | — | -164.1% | ||
| Q3 25 | -1513.5% | -166.1% | ||
| Q2 25 | -4448.7% | -122.7% | ||
| Q1 25 | -8360.9% | -106.5% | ||
| Q4 24 | -4069.6% | -144.1% | ||
| Q3 24 | -4200.9% | -48.0% | ||
| Q2 24 | -4040.4% | -48.6% | ||
| Q1 24 | -2178.6% | -34.4% |
净利率RNASPIR
| Q4 25 | — | -176.6% | ||
| Q3 25 | -1398.3% | -155.3% | ||
| Q2 25 | -4089.3% | 623.4% | ||
| Q1 25 | -7360.0% | -86.5% | ||
| Q4 24 | -3439.5% | -225.2% | ||
| Q3 24 | -3441.7% | -43.7% | ||
| Q2 24 | -3461.8% | -65.2% | ||
| Q1 24 | -1943.4% | -73.3% |
每股收益（稀释后）RNASPIR
| Q4 25 | — | $-0.85 | ||
| Q3 25 | $-1.27 | $-0.61 | ||
| Q2 25 | $-1.21 | $3.72 | ||
| Q1 25 | $-0.90 | $-0.77 | ||
| Q4 24 | $-0.80 | $-1.93 | ||
| Q3 24 | $-0.65 | $-0.50 | ||
| Q2 24 | $-0.65 | $-0.68 | ||
| Q1 24 | $-0.79 | $-1.17 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $350.2M | $81.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.9B | $112.9M |
| 总资产 | $2.1B | $211.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资RNASPIR
| Q4 25 | — | $81.8M | ||
| Q3 25 | $350.2M | $96.8M | ||
| Q2 25 | $243.9M | $117.6M | ||
| Q1 25 | $254.2M | $35.9M | ||
| Q4 24 | $219.9M | $19.2M | ||
| Q3 24 | $370.2M | $36.6M | ||
| Q2 24 | $575.8M | $45.8M | ||
| Q1 24 | $471.4M | $63.7M |
总债务RNASPIR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $103.7M | ||
| Q4 24 | — | $103.1M | ||
| Q3 24 | — | $4.9M | ||
| Q2 24 | — | $4.9M | ||
| Q1 24 | — | $123.1M |
股东权益RNASPIR
| Q4 25 | — | $112.9M | ||
| Q3 25 | $1.9B | $133.1M | ||
| Q2 25 | $1.2B | $149.2M | ||
| Q1 25 | $1.3B | $3.7M | ||
| Q4 24 | $1.4B | $-11.7M | ||
| Q3 24 | $1.5B | $30.8M | ||
| Q2 24 | $1.2B | $40.3M | ||
| Q1 24 | $830.9M | $52.5M |
总资产RNASPIR
| Q4 25 | — | $211.0M | ||
| Q3 25 | $2.1B | $224.3M | ||
| Q2 25 | $1.4B | $239.5M | ||
| Q1 25 | $1.5B | $208.8M | ||
| Q4 24 | $1.6B | $193.6M | ||
| Q3 24 | $1.6B | $224.2M | ||
| Q2 24 | $1.3B | $230.8M | ||
| Q1 24 | $951.5M | $252.3M |
负债/权益比RNASPIR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 27.92× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.16× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 2.35× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-156.2M | $-4.3M |
| 自由现金流经营现金流 - 资本支出 | $-156.9M | $-16.2M |
| 自由现金流率自由现金流/营收 | -1257.6% | -102.1% |
| 资本支出强度资本支出/营收 | 5.7% | 75.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-592.3M | $-92.6M |
8季度趋势，按日历期对齐
经营现金流RNASPIR
| Q4 25 | — | $-4.3M | ||
| Q3 25 | $-156.2M | $-12.0M | ||
| Q2 25 | $-199.7M | $-35.1M | ||
| Q1 25 | $-124.8M | $-8.4M | ||
| Q4 24 | $-99.9M | $-19.2M | ||
| Q3 24 | $-65.6M | $14.0M | ||
| Q2 24 | $-65.0M | $-4.4M | ||
| Q1 24 | $-70.4M | $-8.8M |
自由现金流RNASPIR
| Q4 25 | — | $-16.2M | ||
| Q3 25 | $-156.9M | $-20.4M | ||
| Q2 25 | $-203.0M | $-38.7M | ||
| Q1 25 | $-128.6M | $-17.3M | ||
| Q4 24 | $-103.8M | $-24.3M | ||
| Q3 24 | $-67.3M | $5.1M | ||
| Q2 24 | $-65.5M | $-9.9M | ||
| Q1 24 | $-71.3M | $-15.9M |
自由现金流率RNASPIR
| Q4 25 | — | -102.1% | ||
| Q3 25 | -1257.6% | -161.3% | ||
| Q2 25 | -5277.1% | -201.7% | ||
| Q1 25 | -8174.3% | -72.6% | ||
| Q4 24 | -3491.0% | -112.2% | ||
| Q3 24 | -2881.8% | 17.8% | ||
| Q2 24 | -3204.6% | -39.0% | ||
| Q1 24 | -2012.3% | -45.7% |
资本支出强度RNASPIR
| Q4 25 | — | 75.1% | ||
| Q3 25 | 5.7% | 66.2% | ||
| Q2 25 | 86.9% | 18.8% | ||
| Q1 25 | 238.6% | 37.3% | ||
| Q4 24 | 131.7% | 23.5% | ||
| Q3 24 | 72.9% | 31.2% | ||
| Q2 24 | 26.0% | 21.8% | ||
| Q1 24 | 25.8% | 20.3% |
现金转化率RNASPIR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.29× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
